Genetic variations at microRNA and processing genes and risk of oral cancer

Tumor Biology

Volumn 35, Issue 4, 2014, Pages 3409-3414

  Roy, Roshni ^a   De Sarkar, Navonil ^a   Ghose, Sandip ^b   Paul, Ranjan R ^b   Pal, Mousumi ^b   Bhattacharya, Chandrika ^c   Chowdhury, Shweta K Roy ^c   Ghosh, Saurabh ^a   Roy, Bidyut ^a  

^a INDIAN STATISTICAL INSTITUTE   (India)

^b Guru Nanak Institute of Dental Sciences and Research   (India)

^c National Institute of Bio Medical Genomics   (India)

Author keywords

Cumulative risk; Genetic variation; microRNA; Oral cancer

Indexed keywords

MICRORNA;

ADULT; ARTICLE; CANCER EPIDEMIOLOGY; CANCER RISK; CONTROLLED STUDY; FEMALE; GENETIC EPIDEMIOLOGY; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PRIORITY JOURNAL; RNA PROCESSING; TOBACCO;

ADULT; AGED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84898794275     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1450-3     Document Type: Article

References (31)

1. Elango JK, Gangadharan P, Sumithra S, Kuriakose MA. Trends of head and neck cancers in urban and rural India. Asian Pac J Cancer Prev. 2006;7(1):108-12.
2. Sankaranarayanan R, Ramadas K, Thomas G, Muwonge R, Thara S, Mathew B, et al. Effect of screening on oral cancer mortality in Kerala, India: a cluster-randomised controlled trial. Lancet. 2005;365(9475):1927-33. doi: 10.1016/S0140-6736(05)66658-5.
3. Tanaka T, Tanaka M. Oral carcinogenesis and oral cancer chemoprevention: a review. Pathol Res Int. 2011;2011:431246. doi: 10.4061/2011/431246.
4. Coelho KR. Challenges of the oral cancer burden in India. J Cancer Epidemiol. 2012;2012:701932. doi: 10.1155/2012/701932.
5. Ambros V. The functions of animal microRNAs. Nature. 2001;431:350-5.
6. Bartel B. MicroRNAs directing siRNA biogenesis. Nat Struct Mol Biol. 2005;12:569-71.
7. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007;318:1931-4.
8. Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6:376-85.
9. Jin Y, Lee CGL. Single nucleotide polymorphisms associated with microRNA regulation. Biomolecules. 2013;3:287-302. doi: 10.3390/biom3020287.
10. Wiklund ED, Gao S, Hulf T, Sibbritt T, Nair S, Costea DE, et al. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma. PLoS ONE. 2011;6(11):e27840. doi: 10.1371/journal.pone.0027840 PONE-D-11-13192.
11. Majumder M, Sikdar N, Ghosh S, Roy B. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer. 2007;120(10):2148-56. doi: 10.1002/ijc.22547.
12. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
13. Clague J, Lippman SM, Yang H, Hildebrandt MA, Ye Y, Lee JJ, et al. Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog. 2010;49(2):183-9. doi: 10.1002/mc.20588.
14. Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res. 2008;68(7):2094-105. doi: 10.1158/0008-5472.CAN-07-5194.
15. Ye Y, Wang KK, Gu J, Yang H, Lin J, Ajani JA, et al. Genetic variations in microRNA-related genes are novel susceptibility loci for esophageal cancer risk. Cancer Prev Res (Phila). 2008;1(6):460-9. doi: 10.1158/1940-6207.CAPR-08- 0135.
16. Chen D, Cabay RJ, Jin Y, Wang A, Luo Y, Shah-Khan M et al. MicroRNA deregulations in head and neck squamous cell carcinomas. J Oral Maxillofac Res. 2013; 4(1). doi: 10.5037/jomr.2013.4102.
17. Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N, Callegari E, et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A. 2007;104(40):15805-10. doi: 10.1073/pnas.0707628104.
18. Hu Z, Chen J, Tian T, Zhou X, Gu H, Xu L, et al. Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest. 2008;118(7):2600-8. doi: 10.1172/JCI34934.
19. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81(3):559 - 75. doi: 10.1086/519795.
20. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc. 1995;57(1):289-300.
21. Chauhan G, Spurgeon CJ, Tabassum R, Bhaskar S, Kulkarni SR, Mahajan A, et al. Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2, and CDKAL1 on the risk of type 2 diabetes in 5,164 Indians. Diabetes. 2010;59(8):2068-74. doi: 10.2337/db09-1386.
22. Znaor A, Brennan P, Gajalakshmi V, Mathew A, Shanta V, Varghese C, et al. Independent and combined effects of tobacco smoking, chewing and alcohol drinking on the risk of oral, pharyngeal and esophageal cancers in Indian men. Int J Cancer. 2003;105(5):681-6. doi: 10.1002/ijc.11114.
23. Liu Z, Li G, Wei S, Niu J, El-Naggar AK, Sturgis EM, et al. Genetic variants in selected pre-microRNA genes and the risk of squamous cell carcinoma of the head and neck. Cancer. 2010;116(20):4753-60. doi: 10.1002/cncr.25323.
24. Christensen BC, Avissar-Whiting M, Ouellet LG, Butler RA, Nelson HH, McClean MD, et al. Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res. 2010;16(14):3713-20. doi: 10.1158/1078-0432.CCR-10-0657.
25. Xu Y, Liu L, Liu J, Zhang Y, Zhu J, Chen J, et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int J Cancer. 2011;128(2):412-7. doi: 10.1002/ijc.25342.
26. Li L, Wu J, Sima X, Bai P, Deng W, Deng X, et al. Interactions of miR-34b/c and TP-53 polymorphisms on the risk of nasopharyngeal carcinoma. Tumour Biol. 2013;34(3):1919-23. doi: 10.1007/s13277-013-0736-9.
27. Bensen JT, Tse CK, Nyante SJ, Barnholtz-Sloan JS, Cole SR, Millikan RC. Association of germline microRNA SNPs in pre-miRNA flanking region and breast cancer risk and survival: the Carolina Breast Cancer Study. Cancer Causes Control. 2013;24(6):1099-109. doi: 10.1007/s10552-013-0187-z.
28. Li YC, Song CH, Yang WJ, Dai LP, Wang P, Shi JX, et al. [Correlation between tag single nucleotide polymorphisms of microRNA regulatory genes and the genetic susceptibility of primary liver cancer]. Zhonghua Yu Fang Yi Xue Za Zhi. 2012;46(6):533-7.
29. Muniyappa MK, Dowling P, Henry M, Meleady P, Doolan P, Gammell P, et al. MiRNA-29a regulates the expression of numerous proteins and reduces the invasiveness and proliferation of human carcinoma cell lines. Eur J Cancer. 2009;45(17):3104-18. doi: 10.1016/j.ejca.2009.09.014.
30. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, et al. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res. 2010;16(4):1129-39. doi: 10.1158/1078-0432.CCR-09-2166.
31. Barkley LR, Santocanale C. MicroRNA-29a regulates the benzo[a]pyrene dihydrodiol epoxide-induced DNA damage response through Cdc7 kinase in lung cancer cells. Oncogenesis. 2013;2:e57. doi: 10.1038/oncsis.2013.20.